What is Sciton?
Sciton operates as a premier developer and manufacturer of advanced energy-based medical aesthetic systems. The company is recognized for its engineering excellence, specifically in the design of lasers and light sources that address a wide spectrum of dermatological and aesthetic concerns. By maintaining a rigorous focus on clinical outcomes and technological precision, Sciton has established itself as a trusted partner for medical professionals seeking to integrate high-utility, durable, and versatile equipment into their practices. Its market position is defined by a synthesis of scientific innovation and a deep understanding of the evolving needs within the aesthetic medicine landscape.
How much funding has Sciton raised?
Sciton has raised a total of $4M across 2 funding rounds:
Debt
$2M
Debt
$2M
Debt (2020): $2M with participation from PPP
Debt (2021): $2M led by PPP
Key Investors in Sciton
PPP
Public-Private Partnership
What's next for Sciton?
With the recent influx of capital, Sciton is well-positioned to accelerate its research and development initiatives, focusing on the next generation of energy-based therapeutic devices. The strategic deployment of these funds will likely prioritize the expansion of its global distribution network and the enhancement of its digital infrastructure to support clinical training and practitioner education. As the demand for non-invasive aesthetic procedures continues to rise, Sciton's focus on high-quality manufacturing and clinical reliability will be critical in maintaining its competitive advantage. The company is expected to leverage this financial stability to explore new market segments and further solidify its reputation as a leader in the medical aesthetics industry.
See full Sciton company page
